STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] Sera Prognostics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 notice for SERA (Sera Prognostics, Inc.): The filer reports a proposed sale of 5,263 Class A common shares to be executed through Morgan Stanley Smith Barney LLC on 09/09/2025. The shares were acquired on 09/09/2025 upon Restricted Stock Unit Vesting and payment is listed as Not Applicable. The filing shows 38,061,868 Class A shares outstanding and an aggregate market value for the proposed sale of 16,560. The filer also disclosed three separate Class A common share sales in the past three months: 5,735 shares on 06/09/2025 (gross proceeds 8,224), 945 shares on 06/10/2025 (gross proceeds 1,403), and 5,800 shares on 08/08/2025 (gross proceeds 14,734). The form includes the standard attestation that the filer does not possess undisclosed material adverse information.

Positive

  • Transparent disclosure of the proposed sale, acquisition method (RSU vesting), broker name, and exact share counts
  • Includes prior sales for the past three months with dates and gross proceeds, aiding investor visibility

Negative

  • No officer or director title provided in the filing, so the precise relationship to the issuer is not stated
  • Materiality of sales not contextualized (no percentage of insider holdings provided), limiting assessment of impact

Insights

TL;DR Insiders filed a Form 144 proposing sale of 5,263 RSU-derived shares; recent insider sales are disclosed for investor transparency.

The filing documents a proposed brokered sale of 5,263 Class A shares acquired via restricted stock unit vesting on the same date, with Morgan Stanley Smith Barney LLC named as broker and an aggregate market value reported as 16,560. The filing also lists three prior sales in the past three months totaling 12,480 shares with combined gross proceeds of 24,361. From a securities-compliance perspective this is a routine Form 144 disclosure that provides transparency about intended insider selling; the filing itself does not contain operational or financial performance information.

TL;DR This Form 144 properly discloses an insider sale and prior transactions; it follows Rule 144 reporting requirements.

The document specifies the relationship of the seller to the issuer only by disclosure of the sale and the acquisition method (RSU vesting). It includes the mandatory representation that the signer is not aware of undisclosed material adverse information. The filing lacks any additional corporate governance details such as trading-plan adoption dates or officer/director titles, so governance implications are limited to the disclosed transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for SERA report?

The form reports a proposed sale of 5,263 Class A common shares to be sold through Morgan Stanley Smith Barney LLC on 09/09/2025, acquired via RSU vesting on 09/09/2025.

How many SERA shares were sold by the filer in the past three months?

The filing discloses three sales totaling 12,480 Class A shares: 5,735 on 06/09/2025, 945 on 06/10/2025, and 5,800 on 08/08/2025.

What broker is handling the proposed SERA sale?

The proposed sale is to be executed through Morgan Stanley Smith Barney LLC at 1 New York Plaza, 38th Floor, New York, NY 10004.

What acquisition method is listed for the shares to be sold?

The shares were acquired through Restricted Stock Unit Vesting on 09/09/2025.

Does the filing state whether the filer knows any undisclosed material information?

Yes. The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

130.45M
33.40M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY